Novo Eyes Hair-Loss Market Amid Plans to Diversify (NVO:NYSE)
6 Articles
6 Articles
Novo Nordisk, the maker of Ozempic, is also looking to enter the hair loss treatment market as the Danish drugmaker looks to expand its direct-to-consumer business, Bloomberg reported. We'll be covering similar topics at our Portfolio Investment Day conference on October 21. One of the biggest investment events of the year is coming up, where professional experts will tell you what to invest in now. Register here.
Growing competition in the weight-loss drug market has prompted Denmark's Novo Nordisk to expand its product range. It intends to produce hair loss medications, Bloomberg reports. The manufacturer of Ozempic and Wegova wants to expand its business into direct-to-consumer pharmaceuticals.
Illustrative image Photo: New Nordisk's PexelsCEO tells CNBC to study acquisitions to strengthen drug portfolio
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
